Skip to main content
. 2021 Jan;10(1):241–250. doi: 10.21037/tcr-20-2482

Table 3. Analysis results based on DFS/PFS/RFS.

Stratified study No. of studies No. of patients Pool HR (95% CI) P value Heterogeneity I2 (%) PQ
DFS 4 1,432 1.97 (1.35–2.87) 0 78.80 0.003
RFS 2 745 2.12 (0.65–6.88) 0.213 52.70 0.146
PFS 1 111 1.65 (0.97–2.81)

DFS/PFS/RFS, disease-free survival/progression-free survival/recurrence-free survival.